Articles tagged with "In Depth"

Sort by

The prognosis of UK pathology services

February 7, 2017
NHS pathology laboratories are under immense pressure to do more with less or face closure. Yet it is precisely these vital services which will be key to improving healthcare in...

A very Jovian affair

February 2, 2017
It’s not just the monstrous gravity which gives Jupiter a unique hold over humankind. It has worked its way into our mythologies and become embedded in our imaginations over hundreds...

#Wonderdrug?

January 26, 2017
As the list of medical issues that Cannabis can potentially treat grows – a resistance to fully legalise the drug means questions remain over quality and safety. Using the US...

Let’s get real

January 24, 2017
The humble petri dish has been a stalwart of the lab for as long as cells have been cultured – but does 2D cell growth really represent the environment of...

Mass spec goes 2D

January 19, 2017
No longer side-lined as a computationally-hungry scientific curiosity, two-dimensional mass spectrometry is becoming a fully-fledged analytical technique says Maria van AgthovenOne of the cornerstones of biomedical research is proteomics, which...

Who owns CRISPR?

January 17, 2017
As CRISPR establishes a firm foothold as the gene editing technique of choice, the patent lawyers are braced for what may shape up to be science’s bloodiest commercial battle.

Not just another brick in the wall

January 12, 2017
Far from being an inert capsule, chemical profiling screenings have revealed that the bacterial cell wall is the seat of bacterial defence mechanisms. Understanding them could help us in the...

A complex problem…

January 9, 2017
It has long puzzled scientists why, after 3 billion years of nothing more complex than algae, animals suddenly started to appear on Earth. Here Rosalie Tostevin discusses new evidence which...

The Three Musketeers

January 5, 2017
PARP inhibitors are increasingly becoming seen as a vital tool for use alongside conventional cancer treatments. But what is so special about the trio of PARP1, 2 and 3?As clinical...

Quite the character

December 29, 2016
As biosimilars and biobetters cut in on the traditional biotherapeutics model, one thing is very clear says Kim Colson – the ability to quickly and accurately characterise monoclonal antibodies will...

Pin It on Pinterest